Results 161 to 170 of about 8,114 (214)

Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network. [PDF]

Front Immunol
Wang L, Chen J, Li H, Wang L, Liu F, Jiang X.   +5 more
europepmc   +1 more source

Efgartigimod as Fast-Acting Rescue Therapy in Very Late-Onset Myasthenia Gravis. [PDF]

Neurol Ther
Rini N, D'Amico F, Portera V, Brighina F, Di Stefano V.   +4 more
europepmc   +1 more source

FcRn‐mediated intestinal absorption of IgG anti‐IgE/IgE immune complexes in mice

, 2012
S. Paveglio, Lynn Puddington, Ektor Rafti, Adam Matson   +3 more
openalex   +2 more sources

The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies [PDF]

, 2015
Amita Datta‐Mannan, Jirong Lu, Derrick R. Witcher, Donmienne Leung, Ying Tang, Victor J. Wroblewski   +5 more
openalex   +1 more source

Autoimmune Neuromuscular Disorders at a Molecular Crossroad: Linking Pathogenesis to Targeted Immunotherapy. [PDF]

Int J Mol Sci
Florea AM, Luca DG, Davidescu EI, Popescu BO.   +3 more
europepmc   +1 more source

Predict Non-Targeted Clearance of Therapeutic Antibodies Using a Human FcRn Dependent in vitro Transcytosis Assay

Szynal, Carmin
openalex   +1 more source

Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring. [PDF]

Cancers (Basel)
Monteiro JF, Fernandes A, Tato DG, Moreira E, Ribeiro R, Reguengo H, Gonçalves J, Fresco P.   +7 more
europepmc   +1 more source

Selective decoupling of IgG1 binding to viral Fc receptors restores antibody-mediated NK cell activation against HCMV. [PDF]

Cell Rep
Qerqez AN, Hoffmann K, Lee AG, Pareek S, Hager K, Mishra AK, Delidakis G, Bentley K, Kerr-Jones L, Cabrera M, Nguyen T, Göttler RL, Chowdhury A, Kolb PL, Hengel H, Georgiou G, McLellan JS, Stanton RJ, Nguyen AW, Maynard JA.   +19 more
europepmc   +1 more source

Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier [PDF]

Julien Lafrance‐Vanasse, Shraddha Sadekar, Yanli Yang, Daniela Bumbaca Yadav, William J. Meilandt, Monica K Wetzel-Smith, Hao Cai, Susan Crowell, Nguyễn Văn Hiệp, Vivian Lee, Ben Chih, Mandy Kwong, Pamela Chan, Sara Francesca Santagostino, Donna W. Lee, Shan Chung, Greg A. Lazar, James A. Ernst, Jasvinder K. Atwal   +18 more
openalex   +1 more source

Nipocalimab in the management of generalized myasthenia gravis: a new targeted therapeutic approach. [PDF]

Ann Med Surg (Lond)
Khalid M, Haider E, Khan A, Haider NU.
europepmc   +1 more source